CUVL
Clinuvel Pharmaceuticals Limited - American Depositary Shares (CUVL)
$30
About Clinuvel Pharmaceuticals Limited - American Depositary Shares (CUVL)
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
Details
Daily high
$5.39
Daily low
$5.30
Price at open
$5.38
52 Week High
$8.92
52 Week Low
$5.30
Market cap
274.8M
Dividend yield
0.65%
Volume
3,593
Avg. volume
9,113
P/E ratio
11.74
Clinuvel Pharmaceuticals Limited - American Depositary Shares News
Details
Daily high
$5.39
Daily low
$5.30
Price at open
$5.38
52 Week High
$8.92
52 Week Low
$5.30
Market cap
274.8M
Dividend yield
0.65%
Volume
3,593
Avg. volume
9,113
P/E ratio
11.74